Market Research Report
Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions
|Published by||BCC Research||Product code||762926|
|Published||Content info||288 Pages
Delivery time: 1-2 business days
|Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions|
|Published: December 21, 2018||Content info: 288 Pages||
The global cancer therapeutics market should grow from $128.1 billion in 2018 to $182.0 billion by 2023 at a compound annual growth rate (CAGR) of 7.3% for the period of 2018-2023.
All other cancers therapeutics market should grow from $39.4 billion in 2018 to reach $55.5 billion by 2023 at a CAGR of 7.1% for the period of 2018-2023.
Lung cancer therapeutics market should grow from $16.7 billion in 2018 to reach $24.6 billion by 2023 at a CAGR of 8.0% for the period of 2018-2023.
The report on "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions" presents qualitative and quantitative information on the current market dynamics that are influencing the market. It covers a background to cancer, types of cancer, pathogenesis of cancer, and stages of cancer development, including the mechanisms of metastasis and recurrences. It also includes the disease burden through understanding the epidemiology of various cancers. Treatment patterns, which include the pharmacological approaches (covering cytotoxic/chemotherapy, hormonal therapy, targeted therapy, and combinatorial therapy) and non-pharmacological approaches (including surgeries and radiation) are covered to present the various therapeutic options available for the patients. Also included in the report are analyses of key marketed products; the current clinical trial landscape; patent landscape and recent product approvals; regulatory landscape; and reimbursement landscape across different demographics. An overview of the demographics of key regions, namely, North America, Europe, Asia-Pacific, Latin America and the Middle East, with potential growth is also covered. Strategies of global companies engaged in the cancer therapeutic space and the profiles of top companies are also covered.
The quantitative information covered in the report includes -
Market values provided are based on total revenues of cancer therapeutics drug manufacturers.
As a cancer therapeutics (emphasis on recurrent and metastatic cancer) market report, only pharmacological therapy is covered for computation of the market size. Interventions involving surgeries, radiation, ablations and other medical device interventions are excluded from the market size computation and only qualitative information on the same is covered.